首页 | 本学科首页   官方微博 | 高级检索  
检索        

多肿瘤标志物联合检测在恶性肿瘤诊断中的价值分析
引用本文:王玉芳,李首庆,杨广民,马寅芙,魏兵兵.多肿瘤标志物联合检测在恶性肿瘤诊断中的价值分析[J].中国航天工业医药,2009(3):5-7.
作者姓名:王玉芳  李首庆  杨广民  马寅芙  魏兵兵
作者单位:[1]吉林省长春市中心医院检验科,130051 [2]吉林省人民医院中心实验室,130051
基金项目:吉林省卫生厅重点实验室项目、吉林省科技厅应用基础项目(No.20050564);吉林省科技厅发展计划项目(No.200705449)
摘    要:目的探讨联合检测多肿瘤标志物在恶性肿瘤临床诊断中的应用价值。方法应用多肿瘤标志物蛋白芯片检测系统(C-12)测定902例恶性肿瘤患者和248例健康体检者血清十二种肿瘤标志物水平。结果恶性肿瘤组的阳性率显著高于健康体检组,灵敏度是70.5%,特异性为92.3%。结论运用蛋白芯片技术联合检测多种肿瘤标志物可以提高恶性肿瘤的诊断敏感性.同时也可作为肿瘤普查的手段之一。

关 键 词:肿瘤标志物  联合检测  诊断

Value analysis of combined measurement of multi-tumor markers in malignant tumor diagnosis
Institution:Wang Yufang, Li Shouqing, Yang Guangmin, et al. (Central Hospital of Changchun, Changchun 130051)
Abstract:Objective To investigate the clinical value of the detection of multi-tumor markers. Methods The serums level of 12 common tumor markers were detected by the C-12 system in 902 malignant tumor patients and 248 healthy persons. Results The malignant tumor group had rather significandy higher positive rate than healthy group,the sensitivity was 70.5% and the specificity was 92.3%. Conclusion Combined measurement of multiple serum tumor markers using protein biochip technique .can notably increase the diagnostic sensitivity for malignant tumor,and it can be used as an earlier period tumor surveying tool.
Keywords:Tumor markers Combined measurement Diagnosis
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号